[Identifying gaps between guidelines and clinical practice in Clostridium difficile infection]

Area of Science:

• Infectious Diseases
• Healthcare Epidemiology
• Clinical Practice Guidelines

Background:

• Clostridium difficile infection (CDI) poses a significant challenge in healthcare settings.
• Established guidelines by the Society for Healthcare Epidemiology of America and the Infectious Diseases Society of America (IDSA/SHEA) aim to standardize CDI management.
• Assessing adherence to these guidelines and its impact on patient outcomes is critical for quality improvement.

Purpose of the Study:

• To evaluate the adherence of clinical practice to the IDSA/SHEA Clostridium difficile guidelines.
• To determine the impact of guideline adherence on patient outcomes, including clinical cure, recurrence, and mortality.
• To identify specific guideline recommendations that require improved implementation in clinical practice.

Main Methods:

• A retrospective descriptive study was conducted over 36 months.
• Included patients with symptomatic C. difficile infection confirmed by toxin A/B stool tests.
• Data collected included patient demographics, clinical outcomes, comorbidities, risk factors, and adherence to IDSA/SHEA guidelines.

Main Results:

• Of 87 CDI episodes in 77 patients, 40.2% demonstrated full guideline adherence.
• Adherence was significantly higher in mild-moderate CDI (71.0%) compared to severe (7.4%) and severe-complicated (16.6%) cases.
• Higher adherence was associated with improved clinical cure rates (57% vs. 42%), fewer recurrences (22.2% vs. 77.7%), and lower mortality (25% vs. 75%).

Conclusions:

• Overall adherence to Clostridium difficile management guidelines is suboptimal, especially in severe infections.
• Poor guideline adherence is significantly associated with worse patient outcomes.
• Targeted educational interventions are necessary to enhance adherence and improve patient care for C. difficile infections.